CARLISLE COMPANIES INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CARLISLE COMPANIES INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.00B | Feb 14, 2025 |
| FY2023 | Dec 31, 2023 | $1.13B | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | $1.26B | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | $1.31B | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | $892.60M | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $1.15B | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | $1.50B | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | $1.56B | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | $1.24B | Feb 16, 2024 |
| FY2023 | Dec 31, 2021 | $3.84B | Feb 16, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.02B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.00B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $4.59B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $5.45B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $3.84B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $3.97B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $4.48B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $4.48B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $3.75B | Feb 10, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.07B | Feb 16, 2018 |
| FY2017 | Sep 30, 2017 | $1.09B | Feb 16, 2018 |
| FY2017 | Jun 30, 2017 | $1.07B | Feb 16, 2018 |
| FY2017 | Mar 31, 2017 | $857.30M | Feb 16, 2018 |
| FY2017 | Dec 31, 2016 | $893.50M | Feb 16, 2018 |
| FY2017 | Sep 30, 2016 | $991.00M | Feb 16, 2018 |
| FY2017 | Jun 30, 2016 | $996.90M | Feb 16, 2018 |
| FY2017 | Mar 31, 2016 | $794.00M | Feb 16, 2018 |
| FY2016 | Dec 31, 2015 | $876.20M | Feb 13, 2017 |
| FY2016 | Sep 30, 2015 | $973.10M | Feb 13, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $419.70M | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | $466.10M | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | $477.20M | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | $271.20M | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $355.50M | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | $514.50M | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | $561.20M | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | $434.80M | Feb 16, 2024 |
| FY2019 | Dec 31, 2019 | $308.70M | Feb 10, 2020 |
| FY2019 | Sep 30, 2019 | $380.20M | Feb 10, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $740.70M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.31B | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | $205.50M | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | $265.60M | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | $194.60M | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | $101.70M | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $174.20M | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | $254.70M | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | $301.50M | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | $193.60M | Feb 16, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.00B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.14B | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | $253.60M | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | $299.90M | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | $308.60M | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | $120.70M | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | $209.50M | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | $324.00M | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | $396.10M | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | $275.20M | Feb 16, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.10M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $35.40M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $28.70M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $19.00M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $16.40M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $45.40M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $52.20M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $55.10M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $51.30M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $45.40M | Feb 14, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $745.40M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $722.80M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $625.20M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $623.50M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $507.80M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $603.20M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $629.80M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $625.40M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $532.90M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $495.40M | Feb 14, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.03B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.20B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.00B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $421.70M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $696.70M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $703.10M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $339.20M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $458.70M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $531.20M | Feb 14, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $131.20M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $113.30M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $142.20M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $183.50M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $134.80M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $95.50M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $88.90M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $120.70M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $159.90M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $108.80M | Feb 14, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.26B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.82B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $6.62B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $7.22B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $7.25B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $5.87B | Feb 17, 2022 |
| FY2021 | Dec 31, 2019 | $5.50B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $5.25B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $5.30B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $3.97B | Feb 14, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.80B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $2.46B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $2.83B | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $3.02B | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | $2.63B | Feb 14, 2025 |
| FY2023 | Dec 31, 2020 | $2.54B | Feb 16, 2024 |
| FY2022 | Dec 31, 2019 | $2.64B | Feb 22, 2023 |
| FY2021 | Dec 31, 2018 | $2.60B | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | $2.53B | Feb 11, 2021 |
| FY2019 | Dec 31, 2016 | $2.47B | Feb 10, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.54B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.48B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $1.20B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $1.18B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $1.17B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $1.64B | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $1.62B | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $1.44B | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $1.45B | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $1.02B | Feb 14, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.33B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $6.77B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $5.63B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $5.03B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $4.24B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $3.93B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $3.72B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $3.35B | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $2.82B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.55B | Feb 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $753.50M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $576.70M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $364.80M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $324.40M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $897.10M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $351.20M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $803.60M | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $378.30M | Feb 14, 2019 |
| FY2018 | Dec 31, 2016 | $385.00M | Feb 14, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.89B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $1.89B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.29B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $2.58B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.93B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.08B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.59B | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | $1.59B | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | $1.59B | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | $596.40M | Feb 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 28 | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | 4 | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | 5 | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | 3 | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | 1 | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | 3 | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | 4 | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | 5 | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | 3 | Feb 16, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 17 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 27 | Feb 13, 2026 |
| FY2023 | Dec 31, 2023 | 4 | Feb 16, 2024 |
| FY2023 | Sep 30, 2023 | 5 | Feb 16, 2024 |
| FY2023 | Jun 30, 2023 | 3 | Feb 16, 2024 |
| FY2023 | Mar 31, 2023 | 1 | Feb 16, 2024 |
| FY2023 | Dec 31, 2022 | 3 | Feb 16, 2024 |
| FY2023 | Sep 30, 2022 | 4 | Feb 16, 2024 |
| FY2023 | Jun 30, 2022 | 5 | Feb 16, 2024 |
| FY2023 | Mar 31, 2022 | 3 | Feb 16, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 41.00M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 44.40M | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | 47.70M | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | 50.90M | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 52.90M | Feb 11, 2021 |
| FY2020 | Dec 31, 2019 | 55.70M | Feb 11, 2021 |
| FY2019 | Dec 31, 2018 | 57.96M | Feb 10, 2020 |
| FY2018 | Dec 31, 2017 | 61.84M | Feb 14, 2019 |
| FY2017 | Dec 31, 2016 | 64.26M | Feb 16, 2018 |
| FY2016 | Dec 31, 2015 | 64.05M | Feb 13, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $181.10M | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $172.40M | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $160.30M | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $134.40M | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $112.50M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $112.40M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $102.90M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $93.50M | Feb 11, 2021 |
| FY2019 | Dec 31, 2017 | $92.10M | Feb 10, 2020 |
| FY2018 | Dec 31, 2016 | $84.50M | Feb 14, 2019 |